Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Adipose MSCs for AAA Stabilization
NCT06488898Phase 2Recruiting
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Jun 2024
- Primary completion
- Dec 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic adipose tissue-derived mesenchymal stem cells in abdominal aortic aneurysm (AAA), sponsored by Hospital La Paz Institute for Health Research. Primary endpoint: Safety evaluation of the study intervention at 12 months. Started Jun 2024; status: recruiting.
02
Drugs
allogeneic adipose tissue-derived mesenchymal stem cells
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT06488898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06488898.